EUCTR2010-022040-20-GB进行中（未招募）1 期
A Randomised Controlled Trial of Atorvastatin as an Anti-Inflammatory Agent in Non-Cystic Fibrosis Bronchiectasis - Randomised Controlled Trial of Atorvastatin in Bronchiectasis
HS Lothian0 个研究点目标入组 60 人开始时间: 2010年10月21日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
入选标准
- •Inclusion criteria
- •1) Confirmed diagnosis of bronchiectasis on High Resolution CT scanning
- •2) Able to give informed consent
- •3) Age between 18 and 79 years
- •Are the trial subjects under 18? no
- •Number of subjects for this age range: 0
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 0
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 0
排除标准
- •Exclusion criteria
- •1)Patients chronically colonised with Pseudomonas aeruginosa (defined as two or more isolates of Pseudomonas aeruginosa whilst clinically stable in 6 months prior to the study)
- •2)current smokers or ex-smokers of less than 1 year; >15 pack year history;
- •3)cystic fibrosis;
- •4)active allergic bronchopulmonary aspergillosis;
- •5)active tuberculosis;
- •6)poorly controlled asthma;
- •7)pregnancy or breast feeding;
- •8)known allergy to statins;
- •9)active malignancy; chronic liver disease; established cardiovascular or cerebrovascular disease;
- •10)statin use in the last year;
- •11)patients on long term oral macrolides due to the interaction with statin therapy
研究者
相似试验
进行中（未招募）
1 期
A Randomised Controlled Trial of Atorvastatin as an Anti-Inflammatory Agent in Non-Cystic Fibrosis Bronchiectasis in patients with Pseudomonas Aeruginosa - RCT of Atorvastatin in Bronchiectasis in patients with PseudomonasThe aim of this randomized double blind controlled study is to evaluate the efficacy of a 3 months treatment with atorvastatin versus placebo in patients with clinically significant bronchiectasis.MedDRA version: 14.1Level: PTClassification code 10006445Term: BronchiectasisSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersEUCTR2010-022042-24-GBHS Lothian32
已完成
3 期
A study to evaluate the effect of Atorvastatin in GvHDCondition 1: Acute lymphoblastic leukemia [ALL]. Condition 2: Acute myeloid leukemia [AML].Acute myeloblastic leukemiac91.0C92.0IRCT20140818018842N27Tehran University of Medical Sciences75
招募中
不适用
Evaluation of the effect of Atorvastatin in diabetic type 2 patients in the morning and eveningIRCT20211211053359N1Babol University of Medical Sciences76
招募中
3 期
Effect of Atorvastatin in the management of COVID-19COVID-19.Coronavirus infection, unspecifiedB34.2IRCT20150221021159N7Esfahan University of Medical Sciences60
已完成
3 期
Study of the effect of statins on migrainemigraine headaches.MigraineIRCT20190620043953N2Yazd University of Medical Sciences60